South Wales, June 15 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "MISBA" on May 30. The details about the trademark application no. UK00004211591 published in the journal no. 2025/024 (June 13).
With Stratagem Intellectual Property Management Limited as representative, Harness Therapeutics Limited filed the trademark application for the below mentioned good(s)/service(s).
Class 1 : Chemicals for scientific purposes; chemicals for use in research; chemicals, enzymes, biological preparations in the nature of DNA and RNA for research use; chemicals for use in the preparation and creation of DNA and RNA; enzymes for use in the preparation and creation of DNA and RNA; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use.
Class 5 : Pharmaceutical preparations; medical and veterinary preparations for therapeutic purposes; biological, chemical and biochemical reagents for medical use; DNA, RNA, oligonucleotides, polynucleotides for medical and veterinary use; gene editing enzymes for medical and veterinary use; medical and veterinary preparations containing therapeutic DNA and RNA; pharmaceutical research tools in the nature of biological, chemical and biochemical reagents.
Class 42 : Scientific and technological services and research and design relating thereto; medical and veterinary research services including the manipulation of biological reagents to be used for medical,veterinary or therapeutic purposes; chemical and biological analysis and research services; research into DNA and RNA; research and development into the creation of DNA and RNA; research and development services in the manufacture of synthetic DNA, RNA, genes and oligonucleotides for others; research, development, testing and analysis in the field of genomics, DNA and RNA sequencing, gene synthesis, gene identification, gene cloning, gene expression, gene mapping; molecular biology, next generation sequencing, high-throughput sequencing and bioinformatics; gene-editing services; DNA and RNA modelling services; gene engineering services; research and development services in the creation of genome libraries or collections of biologicals including chemicals and compounds; research and development services in creating libraries or collections of normal and mutated genes; scientific services relating to the discovery, preclinical and clinical development of therapeutic products; consultancy and advisory services relating to the aforesaid services.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004211591
Disclaimer: Curated by HT Syndication.
